Abstract
IntroductionThe success of revascularisation therapies for coronary artery disease (CAD) must be measured by both an improvement in hard clinical endpoints—mortality, repeat revascularisation procedures and myocardial infarction, the traditional focus...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have